The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification
达匹西利(一种细胞周期蛋白依赖性激酶 4/6 抑制剂)治疗伴有 CDK4 扩增的晚期头颈部黏膜黑色素瘤患者的疗效和安全性
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-024-03431-x
Shi, Chaoji; Ju, Houyu; Zhou, Rong; Xu, Shengming; Wu, Yunteng; Gu, Ziyue; Wang, Ying; Chen, Wanling; Huang, Xinyi; Han, Yong; Sun, Shuyang; Li, Chuwen; Wang, Min; Zhou, Guoyu; Zhang, Zhiyuan; Li, Jiang; Ren, Guoxin